Scientific Advisory Board

Michael Luther

David H. Murdock Research Institute

Dr. Luther is the President of the David H. Murdock Research Institute (DHMRI) at the North Carolina Research Campus in Kannapolis, NC.

Prior to joining the DHMRI, Dr. Luther was Vice President and Site Head for the Merck Frosst Center for Therapeutic Research in Canada. Previously Dr. Luther was at GlaxoSmithKline where he was the Vice President in Discovery Research. He also worked at Glaxo and Glaxo-Wellcome in a number of increasing roles of responsibility including creating and leading a business unit focused on the integration of diagnostics and therapeutics called Predictive Medicine. This role involved the licensing of technologies, tests and contractual agreements to facilitate integration of biomarkers with drugs from early development to post-launch.

Earlier in his career, Dr. Luther helped launch and build a biotechnology start-up company, Procept, in Cambridge, MA.

Dr. Luther received his Ph.D. in physical biochemistry from St. Louis University School of Medicine and completed post-doctoral studies at The Salk Institute for Biological Studies where he was a Muscular Dystrophy Fellow. Dr. Luther also has an MBA from the Fuqua Business School at Duke University and a BS in Biochemistry from North Carolina State University.